AstraZeneca equity cut not influenced by Boots

UK – The recent asset allocation shift that saw the £4.2bn (€6.8bn) AstraZeneca pension fund reduce its equity holdings by five percent in favour of fixed income was not influenced by the Boots pension fund getting rid of its entire equity portfolios last October.

You have now reached your article limit

Already a registered user or member? Sign in here

To continue reading, register free today for access

Register Now

Registration also includes access to

IPE Real Assets

Gated access promo

Five reasons to register today

  1. Access to IPE articles from our award-winning editorial team
  2. Unique IPE market data, rankings and tables
  3. In-depth interviews with pension fund leaders
  4. Extensive coverage of latest asset class trends
  5. Comprehensive archive of data, research and intelligence